Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

Completed · Phase 1

Conditions studied: Heart Failure, Type 2 Diabetes Mellitus

In brief

To examine the effect of an increase in plasma beta-hydroxy-butyrate (B-OH-B) levels, spanning the physiologic and pharmacologic range (+0.5, +2.0, and +5.0 mmol/L), on: (i) parameters of left ventricular (LV) systolic and diastolic function utilizing cardiac magnetic resonance imaging (MRI) and (ii) myocardial glucose uptake using positron emission tomography (PET) with 18F-fluoro-2-deoxy-D-glucose in type 2 diabetic patients with Class II-III New York Heart Association (NYHA).

Key facts

Study ID
NCT03560323
Run by
The University of Texas Health Science Center at San Antonio
People needed
41
Starts
2019-01-07
Expected to finish
2024-12-30
Last updated by the study team
2025-09-29

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.